Last reviewed · How we verify
Dose Escalation Safety Study of MM-10-001
The purpose of this study is to evaluate the safety of increasing doses of MM-10-001 and to determine the dose of MM-10-001 that enhances the immune system in normal healthy subjects.
Details
| Lead sponsor | GlycaNova Norge AS |
|---|---|
| Phase | Phase 1 |
| Status | UNKNOWN |
| Enrolment | 50 |
| Start date | 2008-02 |
| Completion | 2008-06 |
Conditions
- Healthy
Interventions
- lentinan
- placebo
Primary outcomes
- Blood safety parameters — every second week
Countries
Norway